Neuroinflammation is increasingly recognized as a key factor in the development and progression of a variety of brain disorders. Chronic neuroinflammation contributes to the breakdown of the blood-brain barrier and the accumulation of toxic proteins, leading to neuronal injury and loss. In the context of neuroinflammation and brain disorders, conditions such as Alzheimer's, Parkinson's, and autoimmune diseases like multiple sclerosis are significantly impacted by this inflammatory response. While initially protective, neuroinflammation can become maladaptive, further promoting brain damage. Advances in research are revealing the role of immune cells, such as microglia and T-cells, in driving neuroinflammation and how this process is directly linked to the progression of neuroinflammation and brain disorders. New therapies targeting neuroinflammatory pathways, including anti-inflammatory cytokines and microglial inhibitors, offer potential treatments to mitigate these effects and slow the progression of brain disorders.
Title : Spring break: A true story of hope and determination
Steven Benvenisti, Davis, Saperstein Salomon, PC, United States
Title : The role of compromised cerebrospinal fluid circulation in sleep apnea
Joe Sam Robinson, Mercer University, United States
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Nervous system effects in chemicals with immediately dangerous to life or health values
Sudha P Pandalai, National Institute for Occupational Safety and Health, United States
Title : Clinical outcomes of AI-augmented cognitive rehabilitation in dementia and mild cognitive impairment
Esra Al, NewDays, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States